To continue, please click the box below to let us know you’re not a robot.
We’ve detected unusual activity from your computer network
For inquiries related to this message please contact our support team and provide the reference ID below.
Why did this happen?
“Right now in Mexico, it’s kind of a standby situation,” said David Pineda Ereño, managing director of DPE International Consulting.
The Ministry of Health body revoked guidelines for a number of reasons, citing that they contravened the decree that allowed for medical cannabis in the country; that the guidelines had not been published in the Official Journal of the Federation; and that they did not have approval of the Foreign Trade Commission therefore contravening customs tariff regulations.
Whether this would be in the form of new guidelines or a regulation remained unclear, he said, but it “could be expected” that this would happen soon, providing clarity on use of cannabis in the future.
The future of cannabis in foods and supplements remains unclear for Mexico following the revocation of guidelines without any next-step plan, but a new regulatory instrument should come soon, says the principal of DPE International Consulting.
On October 30 last year, Mexico’s Federal Commission for the Protection Against Sanitary Risks (COFEPRIS) implemented guidelines and criteria to assess the use of cannabis and its derivatives in foods, beverages and supplements, opening up permits for cannabis-based products with low THC (tetrahydrocannabinol) levels to enter the market. Less than six months later, in March this year, COFEPRIS revoked these guidelines.
“The government has revoked the guidelines but there are, both from the private sector and also from the side of the government, considerations to develop a new regulatory instrument,” Pineda Ereño told NutraIngredients-LATAM.
© Getty Images / Aleksandr_Kravtsov